OGN · Company research
Organon & Co. (OGN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
24records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| OGN Nov 2026 13.000 call (OGN261120C00013000) Interactive Stock Chart - Yahoo! Finance Canada | OGN Nov 2026 13.000 call (OGN261120C00013000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 18, 2026 | neutral | 0 | 0.6 |
| OGN Nov 2026 13.000 call (OGN261120C00013000) Stock Historical Prices & Data - Yahoo! Finance Canada | OGN Nov 2026 13.000 call (OGN261120C00013000) Stock Historical Prices & Data Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 18, 2026 | neutral | 0 | 0.6 |
| Organon & Co. (OGN) stock price, news, quote and history - Yahoo Finance Australia | Organon & Co. (OGN) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 17, 2026 | neutral | 0 | 0.6 |
| OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits | OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal Stocktwits | View source ↗ | Stocktwits | Oct 16, 2026 | neutral | 0 | 0.6 |
| Organon & Co. (OGN) Stock Forecasts - Yahoo Finance | Organon & Co. (OGN) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know | Organon (OGN) is receiving significant investor attention. The pharmaceutical company shows declining earnings estimates for the current fiscal year (-7.9%) but modest growth expected for next year (+7%). Revenue growth remains flat to slightly negative. With a Zacks Rank #3 (Hold) rating and a Grade A valuation score indicating the stock trades at a discount to peers, the company is expected to perform in line with the broader market in the near term. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | neutral | 0 | 1 |
| Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know | Organon (OGN) is receiving significant investor attention. The pharmaceutical company shows declining earnings estimates for the current fiscal year (-7.9%) but modest growth expected for next year (+7%). Revenue growth remains flat to slightly negative. With a Zacks Rank #3 (Hold) rating and a Grade A valuation score indicating the stock trades at a discount to peers, the company is expected to perform in line with the broader market in the near term. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | neutral | 0 | 1 |
| Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance | Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| (OGN) and the Role of Price-Sensitive Allocations - Stock Traders Daily | (OGN) and the Role of Price-Sensitive Allocations Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 13, 2026 | neutral | 0 | 0.6 |
| QCOM Stock Set To Roar Into The Week: OpenAI Smartphone Chip Talk Is Lighting The Fuse - Stocktwits | QCOM Stock Set To Roar Into The Week: OpenAI Smartphone Chip Talk Is Lighting The Fuse Stocktwits | View source ↗ | Stocktwits | Oct 12, 2026 | neutral | 0 | 0.6 |
| Organon (NYSE:OGN) Stock Forecast & Analyst Predictions - Simply Wall Street | Organon (NYSE:OGN) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 12, 2026 | neutral | 0 | 0.6 |
| Organon & Co. (OGN) Stock Price, News & Analysis $OGN - MarketBeat | Organon & Co. (OGN) Stock Price, News & Analysis $OGN MarketBeat | View source ↗ | MarketBeat | Oct 9, 2026 | neutral | 0 | 0.6 |
| Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada | Organon & Co. (OGN) Stock Forecasts Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| Organon & Co. (OGN) Stock Forecasts - Yahoo Finance | Organon & Co. (OGN) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| Orogen Royalties (TSXV:OGN) - Stock Analysis - Simply Wall Street | Orogen Royalties (TSXV:OGN) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Oct 7, 2026 | neutral | 0 | 0.6 |
| Why Did NOK, OGN, XE Stocks Hit 52-Week Highs Today? - Stocktwits | Why Did NOK, OGN, XE Stocks Hit 52-Week Highs Today? Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock | Organon (OGN), a pharmaceutical company, is being closely watched by investors. The stock has underperformed the S&P 500 over the past month (-0.4% vs +0.6%). Earnings estimates remain unchanged with expected EPS of $0.91 for the current quarter (down 9.9% YoY) and $3.37 for the fiscal year (down 7.9% YoY). Revenue is expected to decline slightly. The company received a Zacks Rank #3 (Hold) rating, suggesting it may perform in line with the broader market. However, it is trading at a discount to peers based on valuation metrics. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | neutral | 0 | 1 |
| Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock | Organon (OGN), a pharmaceutical company, is being closely watched by investors. The stock has underperformed the S&P 500 over the past month (-0.4% vs +0.6%). Earnings estimates remain unchanged with expected EPS of $0.91 for the current quarter (down 9.9% YoY) and $3.37 for the fiscal year (down 7.9% YoY). Revenue is expected to decline slightly. The company received a Zacks Rank #3 (Hold) rating, suggesting it may perform in line with the broader market. However, it is trading at a discount to peers based on valuation metrics. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | neutral | 0 | 1 |
| Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - Yahoo Finance | Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock Yahoo Finance | View source ↗ | Yahoo Finance | Oct 2, 2026 | neutral | 0 | 0.6 |
| Organon & Co. (OGN) Short Interest & Short Float | Updated Oct 2026 $OGN - MarketBeat | Organon & Co. (OGN) Short Interest & Short Float | Updated Oct 2026 $OGN MarketBeat | View source ↗ | MarketBeat | Oct 2, 2026 | neutral | 0 | 0.6 |
| Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance | Is Trending Stock Organon & Co. (OGN) a Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 21, 2026 | neutral | 0 | 0.6 |
| Organon Stock Skyrockets 28% Following Reports of $12 Billion Buyout Offer From Sun Pharma - TIKR.com | Organon Stock Skyrockets 28% Following Reports of $12 Billion Buyout Offer From Sun Pharma TIKR.com | View source ↗ | TIKR.com | Apr 13, 2026 | neutral | 0 | 0.6 |
| 3 Reasons to Avoid OGN and 1 Stock to Buy Instead - Yahoo Finance | 3 Reasons to Avoid OGN and 1 Stock to Buy Instead Yahoo Finance | View source ↗ | Yahoo Finance | Apr 13, 2026 | neutral | 0 | 0.6 |
| Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance | Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note Yahoo Finance | View source ↗ | Yahoo Finance | Apr 13, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.